186 related articles for article (PubMed ID: 32093886)
1. Hetero-oligomer formation of mouse UDP-glucuronosyltransferase (UGT) 2b1 and 1a1 results in the gain of glucuronidation activity towards morphine, an activity which is absent in homo-oligomers of either UGT.
Miyauchi Y; Kurita A; Yamashita R; Takamatsu T; Ikushiro S; Mackenzie PI; Tanaka Y; Ishii Y
Biochem Biophys Res Commun; 2020 Apr; 525(2):348-353. PubMed ID: 32093886
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation.
Kurita A; Miyauchi Y; Ikushiro S; Mackenzie PI; Yamada H; Ishii Y
J Pharmacol Exp Ther; 2017 May; 361(2):199-208. PubMed ID: 28228532
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous expression of guinea pig UDP-glucuronosyltransferase 2B21 and 2B22 in COS-7 cells enhances UDP-glucuronosyltransferase 2B21-catalyzed morphine-6-glucuronide formation.
Ishii Y; Miyoshi A; Watanabe R; Tsuruda K; Tsuda M; Yamaguchi-Nagamatsu Y; Yoshisue K; Tanaka M; Maji D; Ohgiya S; Oguri K
Mol Pharmacol; 2001 Nov; 60(5):1040-8. PubMed ID: 11641432
[TBL] [Abstract][Full Text] [Related]
4. Purification of a phenobarbital-inducible UDP-glucuronosyltransferase isoform from dog liver which catalyzes morphine and testosterone glucuronidation.
Oguri K; Kurogi A; Yamabe K; Tanaka M; Yoshisue K; Ishii Y; Yoshimura H
Arch Biochem Biophys; 1996 Jan; 325(2):159-66. PubMed ID: 8561493
[TBL] [Abstract][Full Text] [Related]
5. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.
Pritchard M; Fournel-Gigleux S; Siest G; Mackenzie P; Magdalou J
Mol Pharmacol; 1994 Jan; 45(1):42-50. PubMed ID: 8302279
[TBL] [Abstract][Full Text] [Related]
6. Induction of two UDP-glucuronosyltransferase isoforms sensitive to phenobarbital that are involved in morphine glucuronidation: production of isoform-selective antipeptide antibodies toward UGT1.1r and UGT2B1.
Ishii Y; Takami A; Tsuruda K; Kurogi A; Yamada H; Oguri K
Drug Metab Dispos; 1997 Feb; 25(2):163-7. PubMed ID: 9029046
[TBL] [Abstract][Full Text] [Related]
7. Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds.
King CD; Rios GR; Green MD; MacKenzie PI; Tephly TR
Drug Metab Dispos; 1997 Feb; 25(2):251-5. PubMed ID: 9029056
[TBL] [Abstract][Full Text] [Related]
8. Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac.
King C; Tang W; Ngui J; Tephly T; Braun M
Toxicol Sci; 2001 May; 61(1):49-53. PubMed ID: 11294973
[TBL] [Abstract][Full Text] [Related]
9. UDP-glucuronosyltransferase (UGT) 1A1 mainly contributes to the glucuronidation of trovafloxacin.
Fujiwara R; Sumida K; Kutsuno Y; Sakamoto M; Itoh T
Drug Metab Pharmacokinet; 2015 Feb; 30(1):82-8. PubMed ID: 25760534
[TBL] [Abstract][Full Text] [Related]
10. Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic properties.
Ohno S; Kawana K; Nakajin S
Drug Metab Dispos; 2008 Apr; 36(4):688-94. PubMed ID: 18187562
[TBL] [Abstract][Full Text] [Related]
11. Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver.
Mano Y; Usui T; Kamimura H
Drug Metab Dispos; 2007 Jul; 35(7):1182-7. PubMed ID: 17446261
[TBL] [Abstract][Full Text] [Related]
12. Equine uridine diphospho-glucuronosyltransferase 1A1, 2A1, 2B4, 2B31: cDNA cloning, expression and initial characterization of morphine metabolism.
Hamamoto-Hardman BD; Baden RW; McKemie DS; Knych HK
Vet Anaesth Analg; 2020 Nov; 47(6):763-772. PubMed ID: 32933848
[TBL] [Abstract][Full Text] [Related]
13. Repeated exposure to codeine alters morphine glucuronidation by affecting UGT gene expression in the rat.
Antonilli L; De Carolis L; Brusadin V; Togna AR; Dovizio M; Togna GI; Patrignani P; Nencini P
Eur J Pharmacol; 2012 Oct; 693(1-3):7-14. PubMed ID: 23010468
[TBL] [Abstract][Full Text] [Related]
14. Hepatic microsomal UDP-glucuronosyltransferase (UGT) activities in the microminipig.
Higashi E; Ando A; Iwano S; Murayama N; Yamazaki H; Miyamoto Y
Biopharm Drug Dispos; 2014 Sep; 35(6):313-20. PubMed ID: 24752421
[TBL] [Abstract][Full Text] [Related]
15. Protein-protein interactions between UDP-glucuronosyltransferase isozymes in rat hepatic microsomes.
Ikushiro S; Emi Y; Iyanagi T
Biochemistry; 1997 Jun; 36(23):7154-61. PubMed ID: 9188715
[TBL] [Abstract][Full Text] [Related]
16. Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1.
Watanabe Y; Nakajima M; Ohashi N; Kume T; Yokoi T
Drug Metab Dispos; 2003 May; 31(5):589-95. PubMed ID: 12695347
[TBL] [Abstract][Full Text] [Related]
17. In vivo chronic exposure to heroin or naltrexone selectively inhibits liver microsome formation of estradiol-3-glucuronide in the rat.
Antonilli L; Brusadin V; Milella MS; Sobrero F; Badiani A; Nencini P
Biochem Pharmacol; 2008 Sep; 76(5):672-9. PubMed ID: 18639530
[TBL] [Abstract][Full Text] [Related]
18. Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes.
Williams JA; Ring BJ; Cantrell VE; Campanale K; Jones DR; Hall SD; Wrighton SA
Drug Metab Dispos; 2002 Nov; 30(11):1266-73. PubMed ID: 12386134
[TBL] [Abstract][Full Text] [Related]
19. Glucuronidation of haloperidol by rat liver microsomes: involvement of family 2 UDP-glucuronosyltransferases.
Narayanan R; LeDuc B; Williams DA
Life Sci; 2004 Apr; 74(20):2527-39. PubMed ID: 15010263
[TBL] [Abstract][Full Text] [Related]
20. Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies.
Chau N; Elliot DJ; Lewis BC; Burns K; Johnston MR; Mackenzie PI; Miners JO
J Pharmacol Exp Ther; 2014 Apr; 349(1):126-37. PubMed ID: 24459244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
